Aims
The purpose is to find the gut microbial fingerprinting of pediatric patients with type 1 diabetes.
Methods
The microbiome of 31 children with type 1 diabetes at onset and of 25 healthy children was determined using multiple polymorphic region of the 16S rRNA. We performed machine learning analyses and metagenome functional analysis in order to identify significant taxa and their metabolic pathways content.
Results
Compared with healthy controls, patients showed a significantly higher relative abundance of the following most important taxa: B.stercoris, B.fragilis, B.intestinalis, B.bifidum, Gammaproteobacteria and its descendants, Holdemania, Synergistetes and its descendants. On the contrary the relative abundance of B.vulgatus, Deltaproteobacteria and its descendants, Parasutterella and the Lactobacillus, Turicibacter genera was significantly lower in patients with respects to healthy controls. The predicted metabolic pathway more associated with type 1 diabetes patients concerns "Carbon metabolism", sugar and iron metabolisms in particular. Among the clinical variables considered, BMI-SDS, anti insulin autoantibodies, glycemia, HbA1c, Tanner and age at onset emerged as the most significant positively or negatively correlated with specific clusters of taxa.
Conclusions
The relative abundance and the supervised analyses confirmed the importance of B. stercoris in type 1 diabetes patients at onset and showed a relevant role of Synergistetes and its descendants in patients with respect to healthy controls. In general the robustness and the coherence of the showed results underline the relevance of studying the microbioma using multiple polymorphic regions, different types of analysis and different approaches within each analysis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.